Back to search
FDAFDA · Food and drugs·Recall number Z-0295-2021

Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208

Published November 4, 2020 · Recall initiated: September 14, 2020

Summary

FDA records medical device Class II recall Z-0295-2021, published November 4, 2020 and initiated September 14, 2020. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 72 units; Lot: Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
Foreign: Italy, Spain, and UK
Lot
Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208 recalled?

Yes. FDA published recall Z-0295-2021 on November 4, 2020. Reported hazard: Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail